Business Wire

  1. SAFE-BioPharma Announces Fast, Innovative Identity Proofing Procedure 10/1/2008
    SAFE-BioPharma Association today announced the launch of an innovative, simple, and exceptionally fast procedure for identity proofing and authenticating individuals being equipped with medium assurance digital certificates.
  2. Pfizer Shows Accelerating Pipeline With Significant Growth In Late-Stage Clinical Development 9/30/2008
    Pfizer Inc. today provided the latest update to its development pipeline, showing significant progress in achieving the company’s growth, productivity and performance goals.
  3. Survey Finds U.S. Biopharma Industry Is Moving Steadily Toward Secure Distribution 9/30/2008
    Pharmaceutical Commerce and Blue Vector Systems today announced survey results reporting the U.S. biopharmaceutical industry’s progress in adopting serialization and addressing related supply chain challenges.
  4. FDA Funding Will Increase In Tough Budget Year 9/29/2008
    The Alliance for a Stronger FDA today applauded Congressional actions to assure increased funding for FDA in fiscal year 2009. Under the Continuing Resolution (CR), FDA will be able to spend at a higher rate in FY 2009 than it did in the current fiscal year.
  5. U.S. Food And Drug Administration Selects Applied Biosystems To Provide Mass Spectrometry Instrument Systems For Food Contaminant Testing 9/29/2008
    Applied Biosystems Inc. today announced that the U.S. Food and Drug Administration has purchased seven of the company’s 4000 QTRAP Systems for the analysis of potential harmful pesticides in the U.S. food supply.
  6. Drug Discovery Research Turns To Biomarkers 9/26/2008
    The total drug discovery market in Western Europe was worth $17.40B in 2007, and Frost & Sullivan expects this to grow at a compound annual growth rate of 13.5% to reach $42.08B by 2014.
  7. Reshaping The Behavior Of Markets Where Drugs Play A Central Role 9/23/2008
    Blue Spoon Consulting Group, LLC, today published a framework for pharmaceutical companies to reshape the behavior of markets where drugs play a central role.
  8. Analytical Bio-Chemistry Laboratories' New Pharmaceutical Facility Is Open For Business 9/23/2008
    Analytical Bio-Chemistry Laboratories officially inaugurated its new, 90,000-square-foot pharmaceutical development facility today with a ribbon-cutting ceremony and open house.
  9. CytRx Corporation Completes Acquisition Of Innovive Pharmaceuticals, Inc. 9/22/2008
    CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced the completion of its acquisition of Innovive Pharmaceuticals, Inc.
  10. Technological Innovations Expand The Capabilities Of Mass Spectrometers 9/19/2008
    The acceptance of mass spectrometric techniques in research institutions across Europe is being driven by their inherent advantages such as increased accuracy and higher throughput ratio.